High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

類似資料

• High-dose Cyclophosphamide and Rituximab without Stem Cell Transplantation: a Feasibility Study for Low Grade B cell, Transformed and Mantle Cell Lymphomas
  著者:: Gladstone, Douglas E., 等
  出版事項: (2011)
• Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide
  著者:: Kasamon, Yvette L., 等
  出版事項: (2017)
• Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide
  著者:: DeZern, Amy E., 等
  出版事項: (2020)
• Therapeutic drug monitoring for either oral or intravenous busulfan when combined with pre- and post-transplantation cyclophosphamide
  著者:: Lombardi, Lindsey R., 等
  出版事項: (2015)
• Absence of posttransplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using posttransplantation cyclophosphamide as graft-versus-host disease prophylaxis
  著者:: Kanakry, Jennifer A., 等
  出版事項: (2013)